Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2025Clinical & Translational OncologyOpen Access

SEOM-GEICO clinical guidelines on endometrial cancer (2025)

View Full Paper
Ask AI
Bookmark
Share

Authors

SRSusana RamirezAFAlejandro Pérez FidalgoMGM.P. Barretina Ginesta

Discussion

Loading...

Member takes

Overview

Clinical guidelines summarize evidence for endometrial cancer management, highlighting molecular characterization and treatment approaches.

Key Points

  • Molecular characterization improves risk stratification and may alter treatment recommendations for endometrial cancer.
  • The FIGO 2023 staging emphasizes traditional clinicopathological factors alongside molecular classification to predict outcomes.
  • Adjuvant treatment choices for endometrial cancer must consider risk categories, incorporating radiotherapy, chemotherapy, and hormonal therapies.
  • New therapeutic options in advanced or recurrent endometrial cancer include immunotherapy, alongside established treatments like carboplatin and paclitaxel.

Cite This Study

Ramirez et al. (2025) studied this question.

synapsesocial.com/papers/68d5bd64dc445aa9033b013ehttps://doi.org/10.1007/s12094-025-04046-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Endometrial Cancer: A Daily Clinical Practice Guide for Radiologists2025 · 2 citations
  2. 2Molecular Characterization and Clinical Implications of Endometrial Cancer2025 · 9 citations
  3. 3Integrating Multi-Omics in Endometrial Cancer: From Molecular Insights to Clinical Applications2025
  4. 4Survival Rates and Prognostic Factors Among Patients with Endometrial Cancer2025
  5. 5Molecular Pharmacological Interventions for Endometrial Cancer: A Comprehensive Review2025